FDA warns of another compounding pharmacy recall - Dallas News | myFOXdfw.com

FDA warns of another compounding pharmacy recall

Posted: Updated:
WASHINGTON -

The Food and Drug Administration is warning doctors that a compounding pharmacy is recalling syringes of the Roche drug Avastin after receiving reports of eye infections among patients.

The FDA say Georgia-based Clinical Specialties has received five reports of eye infections from physicians who used the drug to treat macular degeneration, a common vision disorder that affects seniors.

The compounding pharmacy is recalling 40 lots of Avastin distributed to doctors' offices in Georgia, Louisiana, South Carolina and Indiana since December.

Avastin is approved as a cancer drug, but it contains the same active ingredient as Lucentis, another Roche drug approved for macular degeneration. For years, compounding pharmacies have repackaged Avastin into small vials for use by eye doctors. Repackaged injections of Avastin cost about $50, compared with $2,000 for Lucentis.

 

Copyright 2013 The Associated Press

  • CHILDREN'S HOSPITAL HEROESMore>>

  • Hospital Heroes

    Hospital Heroes

    Children's Miracle Network Hospitals raises funds for 170 children's hospitals across the United States and Canada.  Click here for more on our local heroes!
Powered by WorldNow

KDFW FOX 4
400 N. Griffin Street
Dallas, Texas 75202

Main Station Directory:
(214) 720-4444
News Fax:
(214) 720-3263 or (214) 720-3333

Didn't find what you were looking for?
All content © Copyright 2000 - 2014 Fox Television Stations, Inc. and Worldnow. All Rights Reserved.
Privacy Policy | Terms of Service | Ad Choices